Icon

Carasent ASA Stock Analysis and Price Target COMMON STOCK | | LSE

stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

NOK 14.44

0.00 (0.00)%

N/A

6.71K

N/A

N/A

Icon

0H9M:LSE

Carasent ASA (NOK)
COMMON STOCK | LSE
NOK 14.44
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Neutral

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

N/A

N/A

NOK 14.44

Carasent ASA Stock Forecast

N/A

Based on the Carasent ASA stock forecast from 0 analysts, the average analyst target price for Carasent ASA is not available over the next 12 months. Carasent ASA’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Carasent ASA is Neutral, which is based on 0 positive signals and 0 negative signals. At the last closing, Carasent ASA’s stock price was NOK 14.44. Carasent ASA’s stock price has changed by +6.57% over the past week, -5.12% over the past month and -22.00% over the last year.

No recent analyst target price found for Carasent ASA
No recent average analyst rating found for Carasent ASA

Company Overview Carasent ASA

Carasent ASA provides cloud-based medical record services to the health care industry in the Nordic region. The company offers Webdoc, a digital electronic health record (EHR) system; Vårdrummet, a digital platform for communication between patients and therapists, as well as ca...Read More

https://carasent.com

Oevre Slottsgate 2B, Oslo, Norway, 0157

166

December

NOK

UK

Adjusted Closing Price for Carasent ASA (0H9M:LSE)

Loading...

Unadjusted Closing Price for Carasent ASA (0H9M:LSE)

Loading...

Share Trading Volume for Carasent ASA Shares

Loading...

Compare Performance of Carasent ASA Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for 0H9M:LSE

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Carasent ASA (Sector: )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
0R37:LSE
Berkshire Hathaway Inc 0.00 (0.00%) NOK9,223,372,036.85B N/A N/A

ETFs Containing 0H9M

Symbol Name 0H9M's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Carasent ASA (0H9M:LSE) Stock

Stock Target Advisor's fundamental analysis for Carasent ASA's stock is Neutral.

Unfortunately we do not have enough data on 0H9M:LSE's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on 0H9M:LSE's stock to indicate what its average analyst target is.

0H9M:LSE stock's Price/Earning ratio is 0.28. Based on this 0H9M:LSE may be a overvalued for its sector.

The last closing price of 0H9M:LSE's stock was NOK 14.44.

Unfortunately we do not currently have any market capitalization data for 0H9M:LSE's stock.

Unfortunately we do not have enough analyst data on 0H9M:LSE's stock to indicate whether its price will go up or not.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...